Henriette Hansen

Bioanalytiker, Ditzel-gruppen

Telefon nr.65503924
E-mailhvever@health.sdu.dk

J.B. Winsløws Vej 25, 3.
5000 Odense C
Danmark

Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Fingeraftryk

Fingeraftryk er baseret på at anvende teksten fra personernes videnskabelige dokumenter til at skabe et indeks med vægtede emneordskoncepter, som definerer de vigtigste emner for hver enkelt forsker.

59 Lignende profiler

3 Tidsskriftartikel
2 Poster
1 Konferenceabstrakt i tidsskrift

Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients
Gravgaard Thomsen, K. H., Lyng, M. B., Elias, D., (Hansen) Vever, H., Knoop, A. S., Lykkesfeldt, A. E., Lænkholm, A-V. & Ditzel, H. J., dec. 2015, I: Breast Cancer Research and Treatment. 154, 3, s. 483-494
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
Elias, D., (Hansen) Vever, H., Lænkholm, A-V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E. & Ditzel, H. J., 9. apr. 2015, I: Oncogene. 34, s. 1919–1927
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
Global gene expression analysis of tamoxifen-resistant breast cancer cell lines identified a gene signature predictive of clinical outcome of breast cancer patients treated with endocrine therapy
Elias, D., (Hansen) Vever, H., Lykkesfeldt, A. & Ditzel, H., 2014.
Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review
Global gene expression analysis of tamoxifen-resistant breast cancer cell lines identified a gene signature predictive of clinical outcome of breast cancer patients treated with endocrine therapy
Elias, D., (Hansen) Vever, H., Lykkesfeldt, A. & Ditzel, H., 2014, I: Clinical Cancer Research. 74, 1 s., 1887.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review
Gene expression profiling identified FYN as an omportant gene in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
Elias, D., Ditzel, H. & Vever, H., 2013.
Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review

Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Global gene expression analysis of tamoxifen-resistant breast cancer cell lines identified a gene signature predictive of clinical outcome of breast cancer patients treated with endocrine therapy

Global gene expression analysis of tamoxifen-resistant breast cancer cell lines identified a gene signature predictive of clinical outcome of breast cancer patients treated with endocrine therapy

Gene expression profiling identified FYN as an omportant gene in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy